The immunomodulation to diabetes control: New proposals for the reversion of this disease

Diabetes & Metabolic Syndrome
Rafael Dias MâncioEduardo José Caldeira

Abstract

The diabetes mellitus is a metabolic disorder, characterized by the hyperglycemia with deficiency in the use of carbohydrates, fats and proteins, resultant of the impairment in secretion and/or insulin action. Severely, the type 1 diabetes provokes the compromise of several organs, causing different disorders and until death of patient. In this way, the literature has shown the general treatments for the type 1 diabetes and currently the focus in immunotherapy and/or immunomodulation, to control of this hyperglycemic condition. The use of new therapies is necessary due to the high increase of incidence of this disease around the world. Recent studies showed an increase of 40% in the cases since 1997. This disease affects different organs, including the glandular tissues, mainly the pancreas. Despite all therapies for diabetes control, the damages occurred remain irreversible. Thus, in addition to general treatments, the use of immunotherapy may open new perspectives for treatment of this disease. Within this aspect, the anti-CD3 monoclonal antibodies may be effective, mainly by protect and maintain the pancreatic acinar cells. Thus, these treatments based in the immunomodulation can be an option for diabetes control and to reve...Continue Reading

References

Nov 4, 1978·British Medical Journal·G F BottazzoH Festenstein
Jan 4, 1994·Proceedings of the National Academy of Sciences of the United States of America·L ChatenoudJ F Bach
May 31, 2002·The New England Journal of Medicine·Kevan C HeroldJeffrey A Bluestone
Jun 24, 2005·The New England Journal of Medicine·Bart KeymeulenLucienne Chatenoud
Sep 6, 2005·The Anatomical Record. Part A, Discoveries in Molecular, Cellular, and Evolutionary Biology·Eduardo José CaldeiraValéria Helena Alves Cagnon
Oct 2, 2007·Cell Biology International·Eduardo José Caldeira, Valéria Helena Alves Cagnon
Oct 15, 2009·Diabetology & Metabolic Syndrome·Maria Lúcia Corrêa-Giannella, Alexandre S Raposo do Amaral
Feb 11, 2010·Journal of Diabetes Science and Technology·Johnny Ludvigsson, UNKNOWN Linköping Diabetes Immune Intervention Study Group
Dec 17, 2010·World Journal of Gastrointestinal Surgery·Hirofumi Noguchi
Jan 22, 2011·Gut and Liver·Duck Jong Han, David Er Sutherland

❮ Previous
Next ❯

Related Concepts

Related Feeds

Autoimmune Diabetes & Tolerance

Patients with type I diabetes lack insulin-producing beta cells due to the loss of immunological tolerance and autoimmune disease. Discover the latest research on targeting tolerance to prevent diabetes.

Related Papers

Reviews in Endocrine & Metabolic Disorders
Mariela GlandtKevan C Herold
The New England Journal of Medicine
Kevan C HeroldJeffrey A Bluestone
Microscopy Research and Technique
Hugo Tadeu MetidieriEduardo José Caldeira
© 2021 Meta ULC. All rights reserved